Dyadic (DYAI) $7.00 Called a ‘Gamechanger’ – Gets $14 Price Target.
Highly Respected Wall Street Analyst Jason Kolbert Issues $14.00 Price Target On Dyadic.
Investor Presentation Slides From Dyadic (DYA) $6.40.
Really, How Do We Do It?
Live Short Term Chart
Healthcare Incubators and Wearable Devices.
Originally published August 22, 2019
The Global Wearable Devices Market is expected to exceed more than $51.50 billion by...
Armistice Capital Voting on AYTU (AYTU) and Innovus (INNV) Merger.
13D Filing on AYTU (As of the date hereof, each of the Reporting Persons may be deemed to be the beneficial owner...
HCN Navigator Driving ‘Profit at First Touch’ for Hotels.
With more than 80 percent of guests using HCN interactive tablets daily, hoteliers are increasing revenues from onsite services sales and digital...
Innovus (INNV) Gains 75% in Past Week.
After Rough Sledding Post Reverse Split, Client Innovus Receives Buyout Offer From Nasdaq Listed Ayto Biosciences (AYTU).
Click...
AYTU (ATYU) ‘Team’ Letter on Innovus (INNV) Acquisition.
Aytu Team:
I’m pleased to share with you some exciting, transformational news about Aytu BioScience that we announced publicly...
Innovus Pharma Reports 2Q 2019 of $6.8 million, a 27.7% Increase from Prior Quarter.
Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter...
Dalrada (DFCO) Legal Counsel
WEBSITE
CONTINUOUSLY UPDATED
Dalrada Financial Adds Robbe to Board of DirectorsDalrada Financial Corporation Hires Fletcher...
Redefy Corporation* (RDCO) Announces Up to $6 Million Private Securities Offering.
- Rule 506(c) Offering Solely to Accredited Investors -
DENVER, June 05, 2019 (GLOBE NEWSWIRE) -- Redefy Corporation* (a/k/a...
Latest article
Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!
When we added Ardelyx (ARDX) to the Watch List in November of 2022, the market cap near $80 million. Now it's...
GeoVax to Provide Corporate Update on Tuesday May 14, 2024.
Still our favorite biotech microcap, still our favorite management team, and our favorite risk to reward idea with a $4 million market...
NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at the Blink of...
Sanofi (SNY) Announces Partnership - $500 Million Upfront, plus $700 million in Milestones with NovaVax (NVAX). And some investors say Covid is...
